JOHOR BARU: Johor Biotechnology & Biodiversity Corp (J-Biotech) and a South Korean firm, one of the world’s leading medical companies, are jointly working to build a biomedical hub in the state.
Through the venture, the state government plans to create a pharmapolis similar to the one in South Korea by KBIO Health, better known as Osong Medical Park or Osong Bio-Technopolis.
Mentri Besar Datuk Mohamed Khaled Nordin said it was a long-term plan to create the hub, which would house a complete ecosystem at an area that would be identified soon.
“The cooperation between J-Biotech and KBIO Health is a first step to the plan,” he said.
He said they were looking for the right location to build on, “just like when we built the information technology and multimedia hub in Sedenak, and the oil and gas facility in Pengerang”.
He said that coming up with a roadmap for the project would take about six to nine months next year.
Mohamed Khaled was speaking after officiating at the Johor International Bioeconomy Conference at Persada International Convention Centre here yesterday.
He pointed out that the project was an effort by the state government to strengthen the biomedical sector in Johor, which has untapped growth potential and will help shape the state’s future economy.
“In Malaysia, the size of our bio-economy is 11.3%, or RM130.8bil of the country’s GDP in 2015,” he said.
At the event, Mohamed Khaled witnessed a memorandum of understanding (MoU) between J-Biotech, represented by its chief executive officer Asman Shah Abd Rahman and KBIO Health chief executive officer Dr Kyung Sun.
J-Biotech also signed an MoU with another South Korean company, JK Medical Group, to build a wellness centre equipped with rejuvenation and anti-ageing recovery facilities.
It signed a third MoU, with Rimbunan Serantau Sdn Bhd to carry out commercialising activities, including distribution and marketing, of biodegradable packaging materials in the state.
Also, Mohamed Khaled launched the Johor Bioeconomy DNA, a strategic plan for next year, between J-Biotech and Johor BioInvest, to provide a platform and network for local bio-industry players on the global stage.
Did you find this article insightful?